IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Dr. Lal PathLabs IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 638.00 Cr. The company is based in New Delhi and caters to Healthcare sector. Citigroup Global Markets India , Kotak Mahindra Capital Company are the merchant bankers of Dr. Lal PathLabs IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 12th September 2015.
Dr. Lal PathLabs IPO open date is 8th December 2015 and close date is 10th December 2015. IPO Allotment Date is 30th November -0001 and Listing date is 23rd December 2015.
IPO
Size:
₹ 638.00 Cr.
Avg IPO Size (Sector Based)
: ₹
978.00 cr.
Sector: Healthcare
IPO so far:
28
Merchant Banker:
Citigroup Global
IPO by BRLM so far:
72
City:
New Delhi
IPO so far:
126
Revenue (annualised):
₹
815.42
cr. 
PE
Ratio:
48.00x
Average Sector PE Ratio: 27.92x
Dr. Lal PathLabs IPO size is ₹ 638.00 Cr. with IPO price of ₹ 550.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Citigroup Global Markets India Private Limited is the book-running lead manager of the Dr. Lal PathLabs IPO. Link Intime India Private Limited is the Registrar for Dr. Lal PathLabs IPO.
Dr. Lal PathLabs IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Dr. Lal PathLabs IPO, based in New Delhi, operates in the Healthcare sector with a focus on healthcare tests and services. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Dr. Lal PathLabs IPO size is ₹ 638.00 Cr. with fresh issue size of ₹ 638 and Offer for sale being ₹ Nil
The IPO allotment date for Dr. Lal PathLabs IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Dr. Lal PathLabs IPO allotment status on the registrars website, Link Intime India Private Limited . Dr. Lal PathLabs IPO refund dates are 30th November -0001.
Dr. Lal PathLabs IPO is expected to be listed on 23rd December 2015.
The upper price band for the Dr. Lal PathLabs IPO is set at ₹ 550.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Dr. Lal PathLabs IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Dr. Lal PathLabs IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 10th December 2015. After submission, funds are blocked until the basis of allotment of Dr. Lal PathLabs IPO is finalised.
The merchant banker for Dr. Lal PathLabs IPO is Citigroup Global Markets India Private Limited , Kotak Mahindra Capital Company Limited . Citigroup Global Markets India Private Limited , Kotak Mahindra Capital Company Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Dr. Lal PathLabs IPO RHP for further details.
The registrar for Dr. Lal PathLabs IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Dr. Lal PathLabs IPO through their official website or helpline.
Dr. Lal PathLabs IPO was subscribed 33.41 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 638.00 Cr.
Avg IPO Size (Sector Based)
:
₹ 978.00 Cr.
Sector: Healthcare
IPO so far:
28
Merchant Banker:
Citigroup Global
IPO by BRLM so far:
72
City:
New Delhi
IPO so far:
126
Revenue (annualised):
₹ 789.40 cr.
PE
Ratio:
48.00x
Average Sector PE Ratio: 27.92x
Dr. Lal PathLabs IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Dr. Lal PathLabs Financial Review Page
Merchant Banker(s) of Dr. Lal PathLabs IPO: Citigroup Global Markets India Private Limited , Kotak Mahindra Capital Company Limited
Dr. Lal PathLabs IPO subscription was 33.41 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Dr. Lal PathLabs IPO listed at a listing price of 824.15 against the offer price of 550.00.
The current market price of Dr. Lal PathLabs is 3003.50.
Why Us?
